JDJosephine Dresler

Josephine Dresler

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Josephine Dresler has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Prospects and challenges of recombinant spider venom enzymes: insights from Loxosceles and Phoneutria venom protease expressions

    by Josephine Dresler, Ivonne Rodriguez, Anne Paas, Alfredo Cabrera-Orefice, Andreas Vilcinskas, Tim Lüddecke

    Spiders use chemically complex venoms to overpower prey. Such venoms are primarily composed of neurotoxic disulfide-rich peptides, linear peptides, and enzymes. The latter have received little scientific attention thus far, and despite their great translational potential, functional data on spider venom enzymes remain scarce. Hence, a more comprehensive understanding is sought, not only to provide valuable insights into their biological functionality but also to facilitate the development of novel biotechnological applications. However, their chemical isolation is prevented by the minuscule venom yields available from most spiders. Recombinant expression emerged as a promising methodology to overcome these restrictions, but comparatively few efforts have been made to establish technologies for different enzyme families. In particular, few works have explored the pivotally important technical aspects of spider venom enzyme expression, including strain selection, culture conditions, and product purification. In this study, we explore these aspects using two spider venom enzymes as a case study, with particular emphasis on the purification and refolding of an astacin-like metalloprotease from Loxosceles intermedia venom. The enzymes were produced as fusion proteins using diverse Escherichia coli strains to identify the most effective production strains, including their optimal production conditions. Thioredoxin A, a 6x-His-Tag, and a cleavage site for activated factor X allowed efficient purification and subsequent removal of all fusion tags, and we report in detail the purification of the mass spectrometry-confirmed L. intermedia metalloprotease from inclusion bodies. This exploratory study outlines the technical details and potential pitfalls encountered during the development of this production process and provides an important baseline for future attempts to express spider venom enzymes.


  • Open Access

    Enlightening the toxinological dark matter of spider venom enzymes

    by Josephine Dresler, Volker Herzig, Andreas Vilcinskas, Tim Lüddecke

    Spiders produce highly adapted venoms featuring a complex mixture of biomolecules used mainly for hunting and defense. The most prominent components are peptidic neurotoxins, a major focus of research and drug development, whereas venom enzymes have been largely neglected. Nevertheless, investigation of venom enzymes not only reveals insights into their biological functions, but also provides templates for future industrial applications. Here we compared spider venom enzymes validated at protein level contained in the VenomZone database and from all publicly available proteo-transcriptomic spider venom datasets. We assigned reported enzymes to cellular processes and known venom functions, including toxicity, prey pre-digestion, venom preservation, venom component activation, and spreading factors. Our study unveiled extensive discrepancy between public databases and publications with regard to enzyme coverage, which impedes the development of novel spider venom enzyme-based applications. Uncovering the previously unrecognized abundance and diversity of venom enzymes will open new avenues for spider venom biodiscovery.


  • Open Access

    A roadmap to the enzymes from spider venom: biochemical ecology, molecular diversity, and value for the bioeconomy

    by Josephine Dresler, Ignazio Avella, Maik Damm, Ludwig Dersch, Jonas Krämer, Andreas Vilcinskas, Tim Lüddecke

    Spiders are ancient and highly successful predators, which use venom for both predation and defense. Their venoms are complex mixtures of potent biological molecules, emerging as a prolific source of biomolecular innovation in agriculture, biomedicine, and bioeconomy. While small cysteine-rich neurotoxins are typically considered the main components of spider venoms, recent research has shown that spider venoms also contain many high-molecular-weight proteins, especially enzymes. To date, very little is known about the diversity, biochemistry and ecology of these components. Here, we provide the first systematic overview of spider venom enzymes, describing all known examples in terms of their properties and functions in the spider venom system. We argue that the sheer diversity of these neglected spider venom compounds offers significant translational potential and holds great potential for the bioeconomy, reflecting a wide range of technical applications such as industrial production, food processing, and waste management.


  • Open Access

    Venom Ex Machina? Exploring the Potential of Cell-Free Protein Production for Venom Biodiscovery

    by Anne Paas, Josephine Dresler, Lea Talmann, Andreas Vilcinskas, Tim Lüddecke

    Venoms are a complex cocktail of potent biomolecules and are present in many animal lineages. Owed to their translational potential in biomedicine, agriculture and industrial applications, they have been targeted by several biodiscovery programs in the past. That said, many venomous animals are relatively small and deliver minuscule venom yields. Thus, the most commonly employed activity-guided biodiscovery pipeline cannot be applied effectively. Cell-free protein production may represent an attractive tool to produce selected venom components at high speed and without the creation of genetically modified organisms, promising rapid and highly efficient access to biomolecules for bioactivity studies. However, these methods have only sporadically been used in venom research and their potential remains to be established. Here, we explore the ability of a prokaryote-based cell-free system to produce a range of venom toxins of different types and from various source organisms. We show that only a very limited number of toxins could be expressed in small amounts. Paired with known problems to facilitate correct folding, our preliminary investigation underpins that venom-tailored cell-free systems probably need to be developed before this technology can be employed effectively in venom biodiscovery.


  • Open Access

    Enlighting the toxinological dark matter of spider venom enzymes

    by Josephine Dresler, Volker Herzig, Andreas Vilcinskas, Tim Lueddecke

    Spiders produce highly adapted venoms featuring a complex mixture of biomolecules used mainly for hunting and defense. The most prominent components are peptidic neurotoxins, which have been the focus of research and drug development, whereas venom enzymes have been largely neglected. Nevertheless, investigation of venom enzymes not only reveals insights into their biological functions, but also provides templates for future industrial applications. Here we compared spider venom enzymes contained in the VenomZone database and in other publicly available proteo-transcriptomic datasets. We found extensive discrepancies between these sources, revealing a previously unrecognized abundance and diversity of venom enzymes. Furthermore, we assigned the reported enzymes to cellular processes and known venom functions, including toxicity, prey pre-digestion, venom preservation, venom component activation, and venom spreading factors. Our study reveals a gap between databases and publications in terms of enzyme coverage which impedes development of new applications based on the rich and diverse spectrum of enzymes contained in spider venom.